mutant PI3K-alpha targeted therapeutic (ENSEM Therapeutics)

N/A

Report date: 2025/06/11 11:24:33
NME

Base Information

Drug Namemutant PI3K-alpha targeted therapeutic (ENSEM Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsPhosphatidylinositol 3 kinase alpha modulators
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnsem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsem Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A